Thomas Kurz

Heinrich Heine University Düsseldorf

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Eva Hesping

Flinders University

AUSTRALIA

View details

Laís Pessanha de Carvalho

University of Tübingen

GERMANY

View details

Ivan Vokřál

Assistant Professor

Charles University, Faculty of Pharmacy in Hradec Kralove

CZECH REPUBLIC

View details

Tina Skinner-Adams

Associate Professor

Griffith University

AUSTRALIA

View details

Nicole Teusch

Professor

Heinrich Heine University Düsseldorf

GERMANY

View details

Bjoern Burckhardt

heinrich heine university duesseldorf

GERMANY

View details

Wynand Roos

Assistent Professor

Brown University

UNITED STATES

View details

Nobutada Tanaka

Professor

Kitasato University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Kurz

Research Interests

Explore related searches

Contact this professor

Articles (11)

Reverse <i>N</i>-Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy-<scp>d-</scp>xylulose 5-Phosphate Reductoisomerase (DXR)

Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC)

Assessing the Anthelmintic Candidates BLK127 and HBK4 for Their Efficacy on Haemonchus contortus Adults and Eggs, and Their Hepatotoxicity and Biotransformation

Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities

The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines

Total Synthesis of the Antimycobacterial Natural Product Chlorflavonin and Analogs via a Late-Stage Ruthenium(II)-Catalyzed <i>ortho</i>-C(sp<sup>2</sup>)-H-Hydroxylation

QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria Parasites

Designing HDAC-PROTACs: lessons learned so far

Three Small Molecule Entities (MPK18, MPK334 and YAK308) with Activity against Haemonchus contortus In Vitro

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors

In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi)

Collaborators (8)

Eva Hesping

Laís Pessanha de Carvalho

Ivan Vokřál

Tina Skinner-Adams

Nicole Teusch

Bjoern Burckhardt

Wynand Roos

Nobutada Tanaka

Make your next move.